Current and emerging pharmacotherapies for primary CNS lymphoma.
about
Isolated recurrence of secondary CNS lymphoma: case report and literature review.Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma.Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.
P2860
Current and emerging pharmacotherapies for primary CNS lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Current and emerging pharmacotherapies for primary CNS lymphoma.
@en
Current and emerging pharmacotherapies for primary CNS lymphoma.
@nl
type
label
Current and emerging pharmacotherapies for primary CNS lymphoma.
@en
Current and emerging pharmacotherapies for primary CNS lymphoma.
@nl
prefLabel
Current and emerging pharmacotherapies for primary CNS lymphoma.
@en
Current and emerging pharmacotherapies for primary CNS lymphoma.
@nl
P2860
P356
P1476
Current and emerging pharmacotherapies for primary CNS lymphoma.
@en
P2093
Philip J Bierman
Prathima Prodduturi
P2860
P304
P356
10.4137/CMO.S7752
P407
P577
2012-05-21T00:00:00Z